Literature DB >> 30344052

A Potent and Selective PARP11 Inhibitor Suggests Coupling between Cellular Localization and Catalytic Activity.

Ilsa T Kirby1, Ana Kojic2, Moriah R Arnold3, Ann-Gerd Thorsell4, Tobias Karlberg4, Anke Vermehren-Schmaedick3, Raashi Sreenivasan3, Carsten Schultz5, Herwig Schüler4, Michael S Cohen6.   

Abstract

Poly-ADP-ribose polymerases (PARPs1-16) play pivotal roles in diverse cellular processes. PARPs that catalyze poly-ADP-ribosylation (PARylation) are the best characterized PARP family members because of the availability of potent and selective inhibitors for these PARPs. There has been comparatively little success in developing selective small-molecule inhibitors of PARPs that catalyze mono-ADP-ribosylation (MARylation), limiting our understanding of the cellular role of MARylation. Here we describe the structure-guided design of inhibitors of PARPs that catalyze MARylation. The most selective analog, ITK7, potently inhibits the MARylation activity of PARP11, a nuclear envelope-localized PARP. ITK7 is greater than 200-fold selective over other PARP family members. Using live-cell imaging, we show that ITK7 causes PARP11 to dissociate from the nuclear envelope. These results suggest that the cellular localization of PARP11 is regulated by its catalytic activity.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ADP-ribosylation; MARylation; PARP11; PARPs; nuclear envelope

Mesh:

Substances:

Year:  2018        PMID: 30344052     DOI: 10.1016/j.chembiol.2018.09.011

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  20 in total

1.  ADP-ribosyl-binding and hydrolase activities of the alphavirus nsP3 macrodomain are critical for initiation of virus replication.

Authors:  Rachy Abraham; Debra Hauer; Robert Lyle McPherson; Age Utt; Ilsa T Kirby; Michael S Cohen; Andres Merits; Anthony K L Leung; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-15       Impact factor: 11.205

2.  Targeting PARP11 to avert immunosuppression and improve CAR T therapy in solid tumors.

Authors:  Hongru Zhang; Pengfei Yu; Vivek S Tomar; Xiangjie Chen; Matthew J Atherton; Zhen Lu; Hong-Guang Zhang; Shifeng Li; Angelica Ortiz; Jun Gui; N Adrian Leu; Fangxue Yan; Andres Blanco; Mirella L Meyer-Ficca; Ralph G Meyer; Daniel P Beiting; Jinyang Li; Selene Nunez-Cruz; Roddy S O'Connor; Lexus R Johnson; Andy J Minn; Subin S George; Constantinos Koumenis; J Alan Diehl; Michael C Milone; Hui Zheng; Serge Y Fuchs
Journal:  Nat Cancer       Date:  2022-05-30

Review 3.  Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules.

Authors:  Maria Giulia Nizi; Mirko M Maksimainen; Lari Lehtiö; Oriana Tabarrini
Journal:  J Med Chem       Date:  2022-05-24       Impact factor: 8.039

Review 4.  Research Progress on Mono-ADP-Ribosyltransferases in Human Cell Biology.

Authors:  Yujie Gan; Huanhuan Sha; Renrui Zou; Miao Xu; Yuan Zhang; Jifeng Feng; Jianzhong Wu
Journal:  Front Cell Dev Biol       Date:  2022-05-16

5.  Rational design of selective inhibitors of PARP4.

Authors:  Ilsa T Kirby; Ashley Person; Michael Cohen
Journal:  RSC Med Chem       Date:  2021-10-04

6.  ADP-ribosyltransferases, an update on function and nomenclature.

Authors:  Bernhard Lüscher; Ivan Ahel; Matthias Altmeyer; Alan Ashworth; Peter Bai; Paul Chang; Michael Cohen; Daniela Corda; Françoise Dantzer; Matthew D Daugherty; Ted M Dawson; Valina L Dawson; Sebastian Deindl; Anthony R Fehr; Karla L H Feijs; Dmitri V Filippov; Jean-Philippe Gagné; Giovanna Grimaldi; Sebastian Guettler; Nicolas C Hoch; Michael O Hottiger; Patricia Korn; W Lee Kraus; Andreas Ladurner; Lari Lehtiö; Anthony K L Leung; Christopher J Lord; Aswin Mangerich; Ivan Matic; Jason Matthews; George-Lucian Moldovan; Joel Moss; Gioacchino Natoli; Michael L Nielsen; Mario Niepel; Friedrich Nolte; John Pascal; Bryce M Paschal; Krzysztof Pawłowski; Guy G Poirier; Susan Smith; Gyula Timinszky; Zhao-Qi Wang; José Yélamos; Xiaochun Yu; Roko Zaja; Mathias Ziegler
Journal:  FEBS J       Date:  2021-07-29       Impact factor: 5.622

Review 7.  Interplay between compartmentalized NAD+ synthesis and consumption: a focus on the PARP family.

Authors:  Michael S Cohen
Journal:  Genes Dev       Date:  2020-02-06       Impact factor: 11.361

8.  ADP-ribosylation: from molecular mechanisms to human disease.

Authors:  Nicolas C Hoch; Luis M Polo
Journal:  Genet Mol Biol       Date:  2019-12-13       Impact factor: 1.771

9.  Forced Self-Modification Assays as a Strategy to Screen MonoPARP Enzymes.

Authors:  Tim J Wigle; W David Church; Christina R Majer; Kerren K Swinger; Demet Aybar; Laurie B Schenkel; Melissa M Vasbinder; Arne Brendes; Claudia Beck; Martin Prahm; Dennis Wegener; Paul Chang; Kevin W Kuntz
Journal:  SLAS Discov       Date:  2019-12-19       Impact factor: 3.341

10.  ADP-ribosyltransferase PARP11 suppresses Zika virus in synergy with PARP12.

Authors:  Lili Li; Yueyue Shi; Sirui Li; Junxiao Liu; Shulong Zu; Xin Xu; Meiling Gao; Nina Sun; Chaohu Pan; Linan Peng; Heng Yang; Genhong Cheng
Journal:  Cell Biosci       Date:  2021-06-29       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.